Status:
UNKNOWN
TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration
Lead Sponsor:
St. Erik Eye Hospital
Conditions:
Choroidal Neovascularization
Eligibility:
All Genders
50-85 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of the study is to compare photodynamic therapy to transpupillary thermotherapy as a treatment method for choroidal neovascularization in age-related macular degeneration ( AMD). AMD is a ...
Detailed Description
Age-related macular degeneration ( AMD) is a disease affecting the macula, the central area of the retina. There are two main types of AMD. Geographic atrophy ( dry) AMD and neovascular ( wet) AMD. In...
Eligibility Criteria
Inclusion
- Informed consent. Occult or minimally classic choroidal neovascularization. Lesion size \< 5 mm. VA 0.1-0.5. Recent disease progress.
- \< 25% subretinal fibrosis. No contraindications to fluoresceinangiography and ICG.
- \-
Exclusion
- Earlier treatment with argonlaser or PDT, or otherwise treated in the eye with radiation or PPV. Submacular hemorrhage \> 50%. Serous PED \> 25%. Geographic atrophy \> 1 disc and \< 500 um from fovea. Chorioretinal anastomosis. Glaucoma. Diabetes retinopathy with \> 5 microaneurysm. Contraindications to fluoresceinangiography or ICG. Enrollment in other studies. Drugaddiction.
- \-
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
End Date :
January 1 2008
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00260403
Start Date
June 1 2003
End Date
January 1 2008
Last Update
February 3 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Eriks Eye Hospital
Stockholm, Sweden, 16773